TRAF2 facilitates vaccinia virus replication by promoting rapid virus entry.

Area of Science:

• Virology
• Cell Biology
• Immunology

Background:

• Tumor necrosis factor receptor (TNFR)-associated factor 2 (TRAF2) is an intracellular signaling mediator with known antiviral roles.
• TRAF2 is involved in innate and adaptive immunity and stress responses.
• Vaccinia virus (VACV) is a prototype poxvirus used to study viral replication mechanisms.

Purpose of the Study:

• To investigate the role of TRAF2 in VACV replication.
• To determine how TRAF2 influences VACV entry and replication stages.
• To elucidate the mechanism by which TRAF2 promotes VACV infection.

Main Methods:

• TRAF2 expression was reduced using small interfering RNA in HeLa cells and genetic knockout in murine embryonic fibroblasts (MEFs).
• VACV growth, protein production, and cell morphology changes were assessed in TRAF2-deficient cells.
• Virus uncoating, attachment, and entry assays were performed, including the use of inhibitors for JNK signaling and endosomal acidification.

Main Results:

• Loss of TRAF2 significantly reduced VACV replication and viral protein production.
• TRAF2 deficiency led to delayed VACV entry but normal attachment.
• VACV entry into TRAF2-deficient cells was impaired without endosomal acidification, suggesting reliance on the plasma membrane route.

Conclusions:

• TRAF2 is a proviral factor that enhances VACV replication.
• TRAF2 plays a crucial role in promoting efficient VACV entry into host cells.
• The findings suggest TRAF2 facilitates VACV entry, likely via the plasma membrane pathway.